Ir para o conteúdo principal

United States News Todas as matérias

Todas as matérias desta seção, das mais recentes às mais antigas — página 348 de 371.

Grafa
Auto and cars

XPeng deliveries surge 126% in 2025 as global expansion hits 60 markets

XPeng (NYSE:XPEV) cemented its position as a dominant force in the global electric vehicle market, reporting on Thursday that total vehicle deliveries more than doubled in 2025.

The Guangzhou-based automaker delivered 429,445 units for the full year, a 126% increase year-over-year, marking the first time the company has surpassed the 400,000-unit annual milestone.

Leia mais: XPeng deliveries surge 126% in 2025 as global expansion hits 60 markets
Grafa

Commerce Bancshares finalizes FineMark acquisition, expanding wealth footprint

Commerce Bancshares (NASDAQ:CBSH) has finalized its acquisition of FineMark Holdings, marking a major strategic expansion of its private banking and wealth management operations into high-growth markets.

The closing of the deal, effective January 1, 2026, brings together the Midwest banking stalwart with FineMark’s high-touch concierge wealth services.

Leia mais: Commerce Bancshares finalizes FineMark acquisition, expanding wealth footprint
Grafa
Technology

Ecovyst slashes debt with $530M catalyst unit sale to Technip

Ecovyst (NYSE:ECVT) has finalized the sale of its Advanced Materials & Catalysts (AM&C) segment to Technip Energies, marking a decisive shift in its capital structure and industrial focus.

The transaction, completed on January 2, 2026, generated net proceeds of approximately $530 million after taxes and transaction-related expenses.

Leia mais: Ecovyst slashes debt with $530M catalyst unit sale to Technip
Grafa
Health

Mesoblast reshuffles board for commercial pivot as Ryoncil sales surge

Mesoblast (NASDAQ:MESO) has implemented a sweeping reorganization of its Board of Directors, effective January 1, 2026, signaling a definitive shift from a research-heavy biotech to a revenue-driven commercial entity.

The leadership transition follows the company's most transformational period, highlighted by the December 2024 FDA approval and subsequent 2025 launch of Ryoncil (remestemcel-L).

Leia mais: Mesoblast reshuffles board for commercial pivot as Ryoncil sales surge
Grafa
Health

Evotec names Sarah Fakih as global comms and IR chief

Evotec SE (NASDAQ: EVO) announced on January 2, 2026, the appointment of Dr. Sarah Fakih as Executive Vice President, Head of Global Communications and Investor Relations.

In this newly created strategic role, Dr. Fakih will lead an integrated function designed to synchronize Evotec’s corporate messaging with its capital markets strategy.

Leia mais: Evotec names Sarah Fakih as global comms and IR chief